Edwards Lifesciences
Clinical trials sponsored by Edwards Lifesciences, explained in plain language.
A medical device company focused on heart valves and hemodynamic monitoring.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Heart shunt shows promise for easing heart failure symptoms Results expected Nov 2026 (estimated)
- New heart valve registry tracks Long-Term performance Results expected Dec 2026 (estimated)
- New heart valve trial offers hope for patients with rare congenital defects Results expected Dec 2026 (estimated)
- New Catheter-Based valve repair could help heart patients avoid surgery Results expected Dec 2026 (estimated)
- New heart valve fix offers hope for those too sick for surgery Results expected Feb 2027 (estimated)
-
New catheter device aims to fix leaky heart valve without cutting chest
Disease control CompletedThis early study tested a device called the Edwards PASCAL system, which is threaded through a blood vessel to repair the tricuspid valve in the heart. The valve can leak, causing symptoms like shortness of breath and swelling. The study included 65 people with severe leakage who…
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New heart valve technology put to the test in 777 patients
Disease control CompletedThis study tested whether a new way of processing tissue for Edwards heart valves is safe and works well. 777 adults who needed a new aortic or mitral valve took part. Researchers checked for valve problems like wear or calcification over about a year, and will follow patients fo…
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New catheter device offers hope for leaky heart valve patients
Disease control CompletedThis study tested a new device called the Edwards PASCAL system, which repairs leaky mitral heart valves using a thin tube inserted through a blood vessel, avoiding open-heart surgery. It involved 124 adults with moderate-to-severe mitral regurgitation who were candidates for sur…
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New heart valve passes safety check in 57 patients
Disease control CompletedThis study looked at the SAPIEN XT heart valve, which is placed through a thin tube (catheter) to fix a failed valve in the heart's right ventricle. Researchers wanted to confirm it is safe and works well. They enrolled 57 people with a narrowed or leaky heart valve conduit. The …
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New heart valve offers hope for High-Risk chinese patients
Disease control CompletedThis study tested a new heart valve, the SAPIEN 3, in 58 Chinese patients with severe aortic stenosis who were at high risk for traditional open-heart surgery. The valve was implanted using a thin tube through a blood vessel, avoiding the need for open surgery. The main goal was …
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 26, 2026 16:50 UTC